The influx of functional T cells, i.e., T cells that produce anti-tumor cytokines, including IL-2, IFN-γ, and TNF-α, in the TME of the Lm-LLO-ISG15-vaccinated group was higher than that of the Control Lm-treated group. This evidence concerns the gene ISG15 and neoplasm.